Related Experiment Video
Updated: May 2, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical cancer screening
Edward E Partridge1, Nadeem Abu-Rustum, Anna Giuliano
1From 1University of Alabama at Birmingham Comprehensive Cancer Center; 2Memorial Sloan-Kettering Cancer Center; 3Moffitt Cancer Center; 4Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and 5National Comprehensive Cancer Network.
Abstract:
These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort. Therefore, in July 2013, after review and validation of consensus guidelines from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology, the NCCN Guidelines for Cervical Cancer Screening were discontinued.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Cancer Prevention
Some...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Uterus and Cervix
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...

